Zennova Pharmaceuticals Group

BiotechnologySeries AChengdu, Chinazennova.com

Latest round

Series A

Last raised

Aug 2021

Total raised

Undisclosed

Investors

3

About Zennova Pharmaceuticals Group

Based in Chengdu, China, and founded in 2018. Zennova Pharmaceuticals Group is a pharmaceutical company that focuses on the R&D, manufacturing, and sales of new drugs. The company has research and development, and production bases in Chengdu, and USA. The Chengdu production base passed the certifications, such as US FDA, EU EMA, and China cGMP standards. Dahai Guo, The company's chairman of the board and chief executive officer, has served as chairman and CEO over 7 companies, such as PuraCap pharceutical LLC, Humanwell USA LLC.  The company provides ophthalmic drugs, antitumor drugs, antiviral drugs, and cardiovascular drugs. It has technology platform, Liquipuls, integrates with Pulsed Microdialysis (PMD) analysis, microsphere coating, slow and controlled release, nanoparticle technology, optimised delivery technology. Its products are sold to American, Europe, Japan and Southeast Asia.   The company will complete the production base's interior decoration and equipment installation in September 2023, and start the technical transfer of the FDA-approved series of drugs in the fourth quarter.

Who invested in Zennova Pharmaceuticals Group

3 investors across 2 rounds

See all investors in Zennova Pharmaceuticals Group

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Aug 23, 2021

    Amount

    Undisclosed

    Investors

    Locked

  2. Angel

    Dec 10, 2018

    Amount

    Undisclosed

    Investors

    Locked

Questions about Zennova Pharmaceuticals Group

Who invested in Zennova Pharmaceuticals Group?

Zennova Pharmaceuticals Group has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Zennova Pharmaceuticals Group raised?

Zennova Pharmaceuticals Group has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Zennova Pharmaceuticals Group last raise money?

Zennova Pharmaceuticals Group's most recent round on record is a Series A, in Aug 2021.

What does Zennova Pharmaceuticals Group do?

Based in Chengdu, China, and founded in 2018.

Where is Zennova Pharmaceuticals Group headquartered?

Zennova Pharmaceuticals Group is headquartered in Chengdu, China.

Which VCs invest in companies like Zennova Pharmaceuticals Group?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Zennova Pharmaceuticals Group's stage. Their profiles are linked below.

Raising like Zennova Pharmaceuticals Group? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.